Entity family

Browse institutions

Universities, hospitals, research centres, networks, and public bodies. Examples include universities, NHS trusts, research networks.

1articles mentioning institutions

1institution mentions

1distinct institutions extracted

0%of mentions human-reviewed

Active filtersEntity: NCT03362190 ×

NCT03362190

This institution is selected. Its supporting articles are shown below.

NCT033621901

Articles mentioning NCT03362190

1 articles · page 1 of 1

Safety and tolerability of avacincaptad pegol in combination with ranibizumab in treatment-naïve patients with neovascular age-related macular degeneration: results from a phase 1 and phase 2a study

bmjophth · abstract · 2026-02-03 · 1 matching annotations

80.7%

NCT00709527 NCT03362190 ranibizumab geographic atrophy nAMD avacincaptad pegol neovascular age-related macular degeneration ACP

…ation (nAMD), in patients with nAMD.Methods The phase 1 study ( NCT00709527) was a two-part, ascending-dose and parallel-group, open-label …